D.E. Shaw & Co’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.9M | Buy |
2,081,253
+1,998,104
| +2,403% | +$86.3M | 0.06% | 235 |
|
|
2025
Q1 | $2.87M | Buy |
+83,149
| New | +$2.87M | ﹤0.01% | 1650 |
|
|
2024
Q4 | – | Sell |
-80,746
| Closed | -$2.06M | – | 3030 |
|
|
2024
Q3 | $2.06M | Sell |
80,746
-143,382
| -64% | -$3.65M | ﹤0.01% | 1783 |
|
|
2024
Q2 | $5.68M | Sell |
224,128
-193,760
| -46% | -$4.91M | 0.01% | 1205 |
|
|
2024
Q1 | $12.9M | Sell |
417,888
-506,977
| -55% | -$15.7M | 0.01% | 805 |
|
|
2023
Q4 | $37.3M | Sell |
924,865
-416,378
| -31% | -$16.8M | 0.03% | 344 |
|
|
2023
Q3 | $35.4M | Sell |
1,341,243
-291,743
| -18% | -$7.69M | 0.04% | 345 |
|
|
2023
Q2 | $28.1M | Sell |
1,632,986
-599,035
| -27% | -$10.3M | 0.03% | 441 |
|
|
2023
Q1 | $37M | Sell |
2,232,021
-468,803
| -17% | -$7.77M | 0.04% | 349 |
|
|
2022
Q4 | $20.6M | Buy |
2,700,824
+342,755
| +15% | +$2.61M | 0.02% | 584 |
|
|
2022
Q3 | $23.4M | Sell |
2,358,069
-90,390
| -4% | -$898K | 0.03% | 498 |
|
|
2022
Q2 | $22.2M | Sell |
2,448,459
-47,569
| -2% | -$432K | 0.03% | 553 |
|
|
2022
Q1 | $25.3M | Buy |
2,496,028
+1,209,939
| +94% | +$12.3M | 0.02% | 584 |
|
|
2021
Q4 | $21.5M | Buy |
1,286,089
+1,119,497
| +672% | +$18.7M | 0.02% | 671 |
|
|
2021
Q3 | $7.81M | Sell |
166,592
-2,142
| -1% | -$100K | 0.01% | 1168 |
|
|
2021
Q2 | $10.3M | Buy |
168,734
+142,975
| +555% | +$8.72M | 0.01% | 1040 |
|
|
2021
Q1 | $1.59M | Buy |
+25,759
| New | +$1.59M | ﹤0.01% | 1961 |
|
|
2020
Q2 | – | Sell |
-112,589
| Closed | -$3.27M | – | 2619 |
|
|
2020
Q1 | $3.27M | Buy |
+112,589
| New | +$3.27M | 0.01% | 1270 |
|